
Sign up to save your podcasts
Or


As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
By JAMA Network4.6
162162 ratings
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.

38,576 Listeners

43,696 Listeners

27,181 Listeners

134 Listeners

321 Listeners

544 Listeners

696 Listeners

501 Listeners

6,438 Listeners

301 Listeners

264 Listeners

3,364 Listeners

21 Listeners

13 Listeners

10 Listeners

8 Listeners

20 Listeners

30 Listeners

91 Listeners

517 Listeners

369 Listeners

18 Listeners

369 Listeners